StudyRareStudyRare

Glycogen synthesis and breakdown

Log in to star
Carbohydrate metabolism

Last updated Nov 4, 2026

Log in to add personal notes on this page.

Glycogen is a branched chain of glucose units, stored in two places for two purposes. The liver breaks its glycogen down between meals to keep blood glucose up; muscle breaks its own down locally to fuel contraction. A separate lysosomal enzyme also digests glycogen inside lysosomes in every cell. Where the deficient enzyme works (liver, muscle, or lysosome) decides whether the disorder looks like fasting hypoglycemia, exercise intolerance, or a storage disease of heart and muscle.

glycogen synthase, liver formGYS2; adds glucose as UDP-glucose,after a meal when insulin is highglycogen phosphorylase,muscle formPYGM; cuts glucose fromthe outer chains,stopping four residuesshort of each branchGSD V (McArdle disease)debranching enzymeAGL; two active sites,a transferase and a1,6-glucosidase; withoutit, limit dextrin buildsupGSD IIIphosphoglucomutase 1PGM1transporter into the endoplasmicreticulum, then glucose-6-phosphataseSLC37A4, G6PC1GSD Iacid alpha-glucosidaseGAAPompe disease (GSD II)glucoseglycogenglucose-1-phosphatefree glucose frombranch pointsglucose-6-phosphateglycolysis for ATP(muscle)free glucose intoblood (liver)glycogen in thelysosomelysosomal glycogenbroken down
Figure: glycogen built and broken down in liver and muscle, forking at glycogen into the outer chains cut by phosphorylase and the branch points freed by debranching enzyme, then digested in the lysosome, with GSD I, III, and V and Pompe disease at the steps they block.
  1. glucose → glycogen: glycogen synthase (liver form GYS2) adds glucose, as uridine diphosphate glucose (UDP-glucose), to the chains after a meal, when insulin is high.
  2. Glycogen breakdown forks into two enzymes. Outer chains → glucose-1-phosphate: glycogen phosphorylase cuts glucose from the chain ends and stops four residues short of each branch point. The muscle form (PYGM) is blocked in GSD V (McArdle disease).
  3. Branch points → free glucose: debranching enzyme (AGL), with two active sites: a transferase moves the last three glucose residues onto the parent chain, and a 1,6-glucosidase cuts the branch bond to free glucose. Blocked in GSD III, where glycogen with short outer branches, limit dextrin, builds up.
  4. glucose-1-phosphate → glucose-6-phosphate: phosphoglucomutase 1 (PGM1).
  5. In the liver: glucose-6-phosphate → free glucose into the blood. The transporter (SLC37A4) carries it into the endoplasmic reticulum, where glucose-6-phosphatase (G6PC1) removes the phosphate. Blocked in GSD I. In muscle glucose-6-phosphate goes into glycolysis for ATP instead.
  6. In the lysosome, glycogen is broken down: acid alpha-glucosidase (GAA) cuts both its 1,4 and 1,6 bonds. Blocked in Pompe disease (GSD II).
  • GSD I: the liver cannot release glucose from glycogen or from gluconeogenesis, so fasting hypoglycemia is severe. Trapped glucose-6-phosphate overflows into glycogen and fat (hepatomegaly), lactate, triglycerides, and uric acid. Type Ib (SLC37A4) adds neutropenia.
  • GSD III: breakdown stops at the branches and an abnormal short-branched glycogen (limit dextrin) builds up. Hypoglycemia is ketotic and milder than in GSD I. Type IIIa also involves skeletal and heart muscle; IIIb is liver only.
  • GSD V: working muscle cannot use its own glycogen, giving cramps and fatigue in the first minutes of any exercise, and intense exertion can cause rhabdomyolysis. Symptoms ease after a few minutes (the second wind) as blood glucose and fatty acids reach the muscle. Muscle glycogen does not maintain blood glucose, so there is no hypoglycemia.
  • Pompe disease: glycogen fills lysosomes, most harmfully in heart and skeletal muscle. Near-absent activity gives infantile hypertrophic cardiomyopathy and weakness; partial activity gives later-onset weakness and respiratory insufficiency.
  • Also on this pathway, without a page here yet: GSD 0 (hepatic glycogen synthase deficiency, GYS2); GSD VI (liver phosphorylase, PYGL) and GSD IX (phosphorylase kinase, which activates it), both with ketotic hypoglycemia and hepatomegaly; GSD VII (phosphofructokinase, in glycolysis), which mimics McArdle disease, adds mild hemolysis, and is not helped by sugar before exercise; and GSD XIV (PGM1-CDG, PGM1), at phosphoglucomutase 1, described with recurrent rhabdomyolysis.
  • Timing of hypoglycemia: three to four hours after a meal points to a glycogen breakdown defect; after prolonged fasting it points to gluconeogenesis.
  • Lactate and uric acid are high in GSD I and usually normal in GSD III, where ketones rise on fasting and transaminases (plus CK in IIIa) are raised; lipids can be high in both.
  • Glucagon barely raises glucose in GSD I but does raise lactate: glycogen is broken down to glucose-6-phosphate that cannot leave as glucose. For the same reason glucagon is not used to treat the hypoglycemia.
  • The forearm exercise test in GSD V shows a low lactate-to-ammonia ratio: lactate fails to rise because glycolysis is starved, while ammonia rises normally.
  • Acid alpha-glucosidase activity (newborn screening, blood, or fibroblasts) identifies Pompe disease, and CRIM status is checked before enzyme replacement because a CRIM-negative child generally forms high-titer antibodies against the infused enzyme and needs immune modulation from the first infusion.